Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Long Term Debt 2024–2025
Cyclacel Pharmaceuticals, Inc. annual long term debt history from 2025 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Cyclacel Pharmaceuticals, Inc. long term debt as of December 31, 2025: 2,000.
- Cyclacel Pharmaceuticals, Inc. long term debt for 2025 were 2,000.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cyclacel Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $0 |
Cyclacel Pharmaceuticals, Inc. Long Term Debt — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) long term debt over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's long term debt history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.